Adefovir
RxNorm 16521
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 16521 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: adefovir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Adefovir
(Atom ID: 380238)
PTPrescribable
Designated preferred name (PT):
Adefovir
(Atom ID: 380246)
FNPrescribable
Full form of descriptor (FN):
Adefovir (substance)
(Atom ID: 380255)
PTPrescribable
Designated preferred name (PT):
Adefovir-containing product
(Atom ID: 10795707)
FNPrescribable
Full form of descriptor (FN):
Product containing adefovir (medicinal product)
(Atom ID: 9253245)
Patient Education
Adefovir
Adefovir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 12 years of age and older. Adefovir is in a class of medications called nucleotide analogs. It works by decreasing the amount of hepatitis B virus (HBV) in the body. Adefovir will not cure hepatitis B and may not prevent complications of chronic hepatitis B such as cirrhosis of the liver or liver cancer. Adefovir may not prevent the spread of hepatitis B to other people.
[Learn More]
* Please review the disclaimer below.